MedPath

Xiamen Cardiovascular Hospital Xiamen University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

10

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:7

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Not Applicable
7 (100.0%)

Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER).

Not Applicable
Recruiting
Conditions
Mitral R
Mitral Regurgitation
First Posted Date
2025-07-09
Last Posted Date
2025-07-09
Lead Sponsor
Xiamen Cardiovascular Hospital, Xiamen University
Target Recruit Count
112
Registration Number
NCT07055919
Locations
🇨🇳

Structural Heart Disease Unit, Xiamen Cardiovacular Hospital, Xiamen, Fujian, China

Optimized Strategies for Malperfusion Syndrome

Not Applicable
Not yet recruiting
Conditions
Aortic Dissection
First Posted Date
2024-08-01
Last Posted Date
2024-08-01
Lead Sponsor
Xiamen Cardiovascular Hospital, Xiamen University
Target Recruit Count
236
Registration Number
NCT06532838
Locations
🇨🇳

Xiamen Cardiovascular Hospital at Xiamen University, Xiamen, Fujian, China

The China Mviv Registry

Not Applicable
Recruiting
Conditions
Mitral Stenosis
Mitral Regurgitation
Heart Failure
Bioprosthesis Failure
Mitral Stenosis With Insufficiency
First Posted Date
2023-06-29
Last Posted Date
2023-06-29
Lead Sponsor
Xiamen Cardiovascular Hospital, Xiamen University
Target Recruit Count
50
Registration Number
NCT05925335
Locations
🇨🇳

Yan Wang, Xiamen, Fujian, China

Prospective Study of Tailored Management Strategies for Malperfusion Syndrome

Not Applicable
Recruiting
Conditions
Aortic Dissection
First Posted Date
2022-08-26
Last Posted Date
2022-08-26
Lead Sponsor
Xiamen Cardiovascular Hospital, Xiamen University
Target Recruit Count
120
Registration Number
NCT05517356
Locations
🇨🇳

Department of Cardiac Surgery, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China

Dawneo Neoblazar® Transcatheter Tricuspid Valve Edge-to Edge Repair System Pivotal Clinical Trial in Patients With Severe Tricuspid Regurgitation

Not Applicable
Conditions
Tricuspid Regurgitation
First Posted Date
2022-08-11
Last Posted Date
2022-08-11
Lead Sponsor
Xiamen Cardiovascular Hospital, Xiamen University
Target Recruit Count
98
Registration Number
NCT05497141
Locations
🇨🇳

Xiamen Cardiovascular Hospital Xiamen University, Xiamen, Fujian, China

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath